3-[(9-methyl-3-oxa-9-azatricyclo[3.3.1.0~2,4~]non-7-yl)oxy]-3-oxo-2-phenylpropyl 2,2-dimethylpropanoate (35507-99-4)

Identification
Name:	3-[(9-methyl-3-oxa-9-azatricyclo[3.3.1.0~2,4~]non-7-yl)oxy]-3-oxo-2-phenylpropyl 2,2-dimethylpropanoate
CAS:	35507-99-4
Molecular Formula:	C₂₂H₂₉NO₅
Molecular Weight:	387.4694
InChI:	InChI=1/C22H29NO5/c1-22(2,3)21(25)26-12-15(13-8-6-5-7-9-13)20(24)27-14-10-16-18-19(28-18)17(11-14)23(16)4/h5-9,14-19H,10-12H2,1-4H3
Molecular Structure:
Properties
Flash Point:	223.7°C
Boiling Point:	446.2°C at 760 mmHg
Density:	1.21g/cm³
Refractive index:	1.567
Flash Point:	223.7°C
Safety Data

Other Product

3-[(9-methyl-3-oxa-9-azatricyclo[3.3.1.0~2,4~]non-7-yl)oxy]-3-oxo-2-phenylpropyl benzoate
9-methyl-3-oxa-9-azatricyclo[3.3.1.0~2,4~]non-7-yl 3-(acetyloxy)-2-phenylpropanoate
(1R,2R,4S,5S)-9-methyl-3-oxa-9-azatricyclo[3.3.1.0~2,4~]non-7-yl 2,3-dihydroxy-2-phenylpropanoate
(1R,5S)-9-methyl-3-oxa-9-azatricyclo[3.3.1.0~2,4~]non-7-yl (2S)-3-hydroxy-2-phenylpropanoate - 1-phenylpropan-2-amine (1:1)
b-D-Glucopyranosiduronic acid,(2S)-3-[[(1a,2b,4b,5a,7b)-9-methyl-3-oxa-9-azatricyclo[3.3.1.02,4]non-7-yl]oxy]-3-oxo-2-phenylpropyl(9CI)
3-Oxa-9-azoniatricyclo(3.3.1.0(sup 2,4))nonane, 9-butyl-9-methyl-7-((1-oxo-2-propylpentyl)oxy)-, bromide, stereoisomer
α-Hydroxy-α-3-thienyl-2-thiopheneacetic Acid 9-Methyl-3-oxa-9-azatricyclo[3.3.1.02,4]non-7-yl Ester
3-Oxa-9-azoniatricyclo(3.3.1.0(sup 2,4))nonane, 9-methyl-9-(1-methylethyl)-7-((1-oxo-2-propylpentyl)oxy)-, bromide, stereoisomer
(1α,2β,4β,5α,7β)-()-9-methyl-3-oxa-9-azatricyclo[3.3.1.02,4]non-7-yl (hydroxymethyl)phenylacetate hydrochloride
Morphinan-6-ol, 7,8-didehydro-4,5-epoxy-3-ethoxy-17-methyl-, hydrochloride, (5alpha,6alpha)-, mixt. with (7(S)-(1alpha,2beta,4beta,5alpha,7beta))-9-methyl-3-oxa-9-azatricyclo(3.3.1.0(2,4))non-7-yl alpha-(hydroxymethyl)benzeneacetate hydrobromide and sodium (1S)-7,7-dimethyl-2-oxobicyclo(2.2.1)heptane-1-methane sulfonate
3-Oxa-9-azoniatricyclo(3.3.1.0(sup 2,4))nonane, 9,9-dimethyl-7-((1-oxo-2-propylpentyl)oxy)-, bromide, (1-alpha,2-beta,4-beta,5-alpha,7-beta)-
Benzeneacetic acid, a-(hydroxymethyl)-,9-methyl-3-oxa-9-azatricyclo[3.3.1.02,4]non-7-yl ester, hydrobromide, hydrate(2:3), [7(S)-(1a,2b,4b,5a,7b)]- (9CI)
5-oxo-L-proline, compound with [7(S)-(1α,2β,4β,5α,7β)]-9-methyl-3-oxa-9-azatricyclo[3.3.1.02,4]non-7-yl α-(hydroxymethyl)benzeneacetate (1:1)
(1S,2R,4S,5S)-7-[(3-hydroxy-2-phenylpropanoyl)oxy]-9-methyl-9-nonyl-3-oxa-9-azoniatricyclo[3.3.1.0~2,4~]nonane methyl sulfate
Card-20(22)-enolide, 5,14-dihydroxy-3-(((7-(3-hydroxy-1-oxo-2-phenylpropoxy)-3-oxa-9-azoniatricyclo(3.3.1.0(sup 2,4))non-9-yl)acetyl)oxy)-19-hydroxy-, bromide, (3-beta,(1-alpha,2-beta,4-beta,5-alpha,7-beta(S)),5-beta)-
9,9-dimethyl-7-({2-phenyl-3-[(phenylcarbamoyl)oxy]propanoyl}oxy)-3-oxa-9-azoniatricyclo[3.3.1.0~2,4~]nonane
[7(S)-(1α,2β,4β,5α,7β)]-3-oxa-9-azatricyclo[3.3.1.02,4]non-7-yl (hydroxymethyl)phenylacetate
(1R,5S)-7-{[hydroxy(dithiophen-2-yl)acetyl]oxy}-9,9-dimethyl-3-oxa-9-azoniatricyclo[3.3.1.0~2,4~]nonane bromide hydrate (1:1:1)
9-butyl-7-{[(2S)-3-hydroxy-2-phenylpropanoyl]oxy}-9-methyl-3-oxa-9-azoniatricyclo[3.3.1.0~2,4~]nonane bromide - 7-chloro-3-hydroxy-5-phenyl-1,3-dihydro-2H-1,4-benzodiazepin-2-one (1:1:1)
9-butyl-7-[(3-hydroxy-2-phenylpropanoyl)oxy]-9-methyl-3-oxa-9-azoniatricyclo[3.3.1.0~2,4~]nonane bromide - N~2~-benzoyl-N,N-dipropyl-alpha-glutamine (1:1:1)